UNRESECTABLE HEPATOCELLULAR CARCINOMA
Clinical trials for UNRESECTABLE HEPATOCELLULAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE HEPATOCELLULAR CARCINOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test radiation 'One-Two Punch' to rally Body's defenses against liver cancer
Disease control OngoingThis early-stage study is testing the safety and effectiveness of a two-step treatment for advanced liver cancer that cannot be surgically removed. First, patients receive a targeted radiation treatment directly to the liver tumor. Then, they receive two immunotherapy drugs desig…
Matched conditions: UNRESECTABLE HEPATOCELLULAR CARCINOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Precision proton beams battle standard radiation in liver cancer showdown
Disease control OngoingThis study compares two types of radiation therapy for patients with liver cancer that cannot be removed by surgery. Researchers want to see if proton therapy, which can target tumors more precisely, helps patients live longer with fewer side effects than standard photon radiatio…
Matched conditions: UNRESECTABLE HEPATOCELLULAR CARCINOMA
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Major cancer centers reveal survival data for advanced liver cancer treatment
Disease control OngoingThis study looked back at medical records of 800 patients with advanced liver cancer that couldn't be surgically removed. Researchers examined how well patients did when treated with lenvatinib-based drug combinations, tracking survival rates up to 5 years. The goal was to unders…
Matched conditions: UNRESECTABLE HEPATOCELLULAR CARCINOMA
Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Custom radiation doses target liver cancer more precisely
Disease control OngoingThis study tests whether customizing radiation doses for each patient's liver cancer can improve treatment results. Researchers are giving 42 patients with advanced, inoperable liver cancer precisely measured radiation doses directly to their tumors. The goal is to see if persona…
Matched conditions: UNRESECTABLE HEPATOCELLULAR CARCINOMA
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New drug combo tested for Tough-to-Treat liver cancer
Disease control OngoingThis study is testing whether a new drug called pevonedistat can help control advanced bile duct cancer that starts in the liver. It is being tested alone and in combination with two standard chemotherapy drugs (carboplatin and paclitaxel) in about 40 patients whose cancer has wo…
Matched conditions: UNRESECTABLE HEPATOCELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New hope for liver cancer patients when first treatment fails
Disease control OngoingThis study is for people with advanced liver cancer that has continued to grow despite receiving a specific prior treatment (atezolizumab plus bevacizumab). It aims to see if adding the drug atezolizumab to one of two other cancer drugs (lenvatinib or sorafenib) helps patients li…
Matched conditions: UNRESECTABLE HEPATOCELLULAR CARCINOMA
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Major asian study tests new hope for advanced liver cancer patients
Disease control OngoingThis study looks back at how well a standard drug combination works when doctors also use local treatments like chemoembolization or radiation in real-world patients with advanced liver cancer. Researchers are analyzing data from about 1,136 patients across China and Asia to see …
Matched conditions: UNRESECTABLE HEPATOCELLULAR CARCINOMA
Sponsor: Zhongda Hospital • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
Tiny radiation beads target liver tumors in new trial
Disease control OngoingThis study tests a targeted radiation treatment for liver cancer that cannot be surgically removed. Doctors inject tiny radioactive beads directly into the liver's blood supply to attack tumors while sparing healthy tissue. The trial will measure how well the tumors shrink, how l…
Matched conditions: UNRESECTABLE HEPATOCELLULAR CARCINOMA
Phase: NA • Sponsor: Sirtex Medical • Aim: Disease control
Last updated Feb 27, 2026 15:17 UTC